These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11702867)

  • 1. Craniosynostosis and fetal exposure to sodium valproate.
    Lajeunie E; Barcik U; Thorne JA; El Ghouzzi V; Bourgeois M; Renier D
    J Neurosurg; 2001 Nov; 95(5):778-82. PubMed ID: 11702867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metopic suture craniosynostosis: sodium valproate teratogenic effect. Case report].
    Assencio-Ferreira VJ; Abraham R; Veiga JC; Santos KC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-B):417-20. PubMed ID: 11460190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longer term outcome of children born to mothers with epilepsy.
    Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metopic craniosynostosis, probable effect of intrauterine exposure to maternal valproate treatment].
    Chabrolle JP; Bensouda B; Bruel H; Simon A; Poinsot J; Ickowicz V; Degre S
    Arch Pediatr; 2001 Dec; 8(12):1333-6. PubMed ID: 11811028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of fetal valproate syndrome with new features expanding the phenotype.
    Seidahmed MZ; Miqdad AM; Al-Dohami HS; Shareefi OM
    Saudi Med J; 2009 Feb; 30(2):288-91. PubMed ID: 19198722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal sodium valproate exposure causes Baller-Gerold syndrome phenotype: both phenotypes in the same family.
    Ozdemir OM; Kiliç I; Ozsari T; Kiliç BA; Faivre L; Aral B; Gürses D; Semerci CN
    Turk J Pediatr; 2009; 51(6):631-6. PubMed ID: 20196403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal intelligence in children with prenatal exposure to carbamazepine.
    Gaily E; Kantola-Sorsa E; Hiilesmaa V; Isoaho M; Matila R; Kotila M; Nylund T; Bardy A; Kaaja E; Granström ML
    Neurology; 2004 Jan; 62(1):28-32. PubMed ID: 14718692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.
    Cummings C; Stewart M; Stevenson M; Morrow J; Nelson J
    Arch Dis Child; 2011 Jul; 96(7):643-7. PubMed ID: 21415043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of fetal valproate syndrome with new features expanding the phenotype.
    Al-Mendalawi MD; Seidahmed MZ
    Saudi Med J; 2009 Jul; 30(7):977; author reply 977-8. PubMed ID: 19618023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Valproate treatment during pregnancy: description of four cases with foetal valproate syndrome].
    Sabers A; Larsen K; Blichfeldt S; Sahlholdt L; Rasmussen JO
    Ugeskr Laeger; 2009 Jan; 171(4):221-5. PubMed ID: 19174036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal Valproate Syndrome - Still a Problem Today!
    Wiedemann K; Stüber T; Rehn M; Frieauff E
    Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Embryofetopathy due to valproate: a pathology only little known. Apropos of 4 cases].
    Espinasse M; Manouvrier S; Boute O; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):896-9. PubMed ID: 8949354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate.
    Mawer G; Clayton-Smith J; Coyle H; Kini U
    Seizure; 2002 Dec; 11(8):512-8. PubMed ID: 12464511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal exposure to sodium valproate associated with Baller-Gerold syndrome: case report and review of the literature.
    Santos de Oliveira R; Lajeunie E; Arnaud E; Renier D
    Childs Nerv Syst; 2006 Jan; 22(1):90-4. PubMed ID: 15789214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy.
    Wood AG; Nadebaum C; Anderson V; Reutens D; Barton S; O'Brien TJ; Vajda F
    Epilepsia; 2015 Jul; 56(7):1047-55. PubMed ID: 25963613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cognitive development in children born to women with epilepsy: a prospective report.
    Bromley RL; Mawer G; Love J; Kelly J; Purdy L; McEwan L; Briggs M; Clayton-Smith J; Shi X; Baker GA;
    Epilepsia; 2010 Oct; 51(10):2058-65. PubMed ID: 20633039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
    Viinikainen K; Eriksson K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Behav; 2006 Dec; 9(4):636-40. PubMed ID: 17049311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.